Videos

The fight against breast cancer does not stop with overcoming cancer. 1 in 3 women continue to experience pain symptoms even during a harmless activity such as cycling. Physiotherapist Eva Roose (VUB) wants to help these breast cancer survivors reset their pain alarms.

Anyone who has ever looked for Waldo knows how hard he is to find. In her research on lung cancer, Rebekka Van Hoof (Uhasselt - KU Leuven - VITO) faces a similar task: she is searching within more than 100,000 so-called extracellular vesicles for 2 types -say 'Waldos'- that can help detect the disease early. But she is determined to narrow her search field. How? Watch her explain it in this video. 

Cancer is a sneaky disease. For instance, cancer cells sometimes manage to disguise themselves, outrunning our immune system. Gils Roex (UAntwerpen - FWO) explains how equipping our white blood cells with a cleverly designed CAR could well help win the race against blood cancer. Want to know more? Fasten your seatbelts & watch the video 🏎

Do you remember Pac-Man, from that old skool computer game? Well, did you know that there are Pac-Mans in every single cell of our body? They're called enzymes. Some of these enzymes work too fast or too slow, and this can cause severe diseases. Michaela Prothiwa (KU Leuven) explains how she wants to track down these malfunctioning enzymes using a clever piece of chemistry.

What if you only had 15 months to live? Hard to imagine, right? Yet every day, around 1,000 people worldwide hear this news. The verdict: glioblastoma, a malignant brain tumor. Yet a small group of patients manages to survive for more than 10 years with such a brain tumor. Brecht Decraene wants to finds out why.

Why do cancer patients relapse despite receiving treatment? This is often due to dormant cancer cells. These cells lie dormant in the body and manage to escape treatment, for example, chemotherapy. Can substances from camel and llama blood provide a breakthrough?

Did you know that cancer cells are not so different from our healthy cells? This makes it difficult for T-cells, important immune cells in our body, to recognise and fight cancer cells. Cancer researcher Heleen Hanssens (VUB-FWO) wants to give T-cells a helping hand by equipping them with more sensitive receptors, or antennae, that are pre-programmed to unmask cancer cells. In the lab, she is looking for the perfect form for these CAR antennae, so that they become more stable and better at detecting cancer cells. 

Radiation can save the lives of people with head and neck cancer. Unfortunately, many patients develop swallowing disorders as a result of the treatment, which makes it impossible for them to eat solid food. Leen Van den Steen (UAntwerpen - UZA) wants to help them. How? With tongue strength training.

"Each person is unique. So why do we still treat every woman with ovarian cancer the same way?" Liselore Loverix (KU Leuven - FWO) examines patient by patient and looks for errors in the DNA of their tumour cells. In this way, before treatment starts, she identifies which patient would benefit from a new, targeted therapy based on cancer drugs.

Thanks to new radiotherapy techniques, more and more patients with head and neck cancer are surviving. But for 70% of them, this radiation causes chronic swallowing problems, making it difficult to eat and drink. Hanne Massonet hopes to help them enjoy food and drink again by training their tongue, mouth, and throat muscles.

Have you ever tried to get the last cookie from the bottom of the jar but couldn't quite reach it? Now, what if that cookie can potentially help cure cancer? Wiktoria Wojtaczka (KU Leuven) is investigating terbium, a chemical element that can be turned into a drug for cancer. But the problem she faces in her research is pretty similar to that of the cookie stuck in the jar

Did you know that colon cancer is the third most deadly cancer worldwide? Unfortunately, while immunotherapy is quite effective in the treatment of many cancers, such as skin cancer, it only works in 5% of colon cancer patients. Sara Verbandt (KU Leuven) explains how she wants to make immunotherapy stand up against colon cancer.